J&P (China) Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

J&P (China) Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-16,600	Closed	-$7.42M	–	10
2017 Q3	$7.42M	Hold	16,600	–	–	1.27%	11
2017 Q2	$8.15M	Hold	16,600	–	–	1.72%	9
2017 Q1	$6.43M	Hold	16,600	–	–	2.23%	5
2016 Q4	$6.2M	Hold	16,600	–	–	1.86%	5
2016 Q3	$6.67M	Hold	16,600	–	–	1.82%	7
2016 Q2	$5.8M	Sell	16,600 -14,708	-47%	-$5.66M	1.87%	8
2016 Q1	$11.3M	Buy	31,308 +14,708	+89%	+$6.06M	3.16%	4
2015 Q4	$9.01M	Hold	16,600	–	–	1.98%	8
2015 Q3	$7.72M	Sell	16,600 -1,700	-9%	-$913K	1.61%	10
2015 Q2	$9.34M	Hold	18,300	–	–	1.29%	9
2015 Q1	$8.26M	Hold	18,300	–	–	1.17%	13
2014 Q4	$7.51M	Buy	+18,300	New	+$7.2M	0.76%	14

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

J&P (China) Capital Management's REGN Position: Q4 2017 in Review

J&P (China) Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2017, closing a stake of 16,600 shares — an estimated $7.42M sold.

J&P (China) Capital Management first reported a position in REGN in Q4 2014 and held it in 12 quarters. The position peaked at $11.3M in Q1 2016. 638 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

J&P (China) Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
J&P (China) Capital Management sold 16,600 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $7.42M.
J&P (China) Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 12 quarters.
J&P (China) Capital Management's Regeneron Pharmaceuticals position peaked at $11.3M in Q1 2016.
638 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on J&P (China) Capital Management's 13F filing for Q4 2017.